Essential Partners’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
DCP
Essential Partners's AGL Position: Q2 2026 in Review
Essential Partners reduced its Agilon Health (AGL) stake by 67% in Q2 2026, selling an estimated $162K and leaving 1,219 shares worth $131K. The position accounts for 0.06% of the portfolio, ranked #347.
Essential Partners first reported a position in AGL in Q2 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.
- Essential Partners held 1,219 shares of Agilon Health worth $131K as of Q2 2026.
- Essential Partners sold 2,471 Agilon Health shares in Q2 2026, an estimated $162K.
- Agilon Health made up 0.06% of Essential Partners's portfolio in Q2 2026, its #347 holding.
- Essential Partners first reported a position in Agilon Health in Q2 2025 and has held it in 5 quarters since.
- 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.
Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.